Labcorp Holdings Inc. (LH) Return on Equity (ROE): 10.79%
Is Labcorp Holdings Inc.’s return on equity (ROE) high or low?
Labcorp Holdings Inc.'s return on equity (ROE) of 10.79% is 16% below its 5-year average of 12.84%, around the middle of its 5-year range (5.31%–23.14%).
As of Sunday, June 14, 2026. 11.07% above its 12-month average of 9.71%.
LH Return on Equity (ROE) Chart
LH Average Return on Equity (ROE) Chart
LH Current vs Average Return on Equity (ROE) Chart
LH Return on Equity (ROE) Metrics
RETURN ON EQUITY (ROE)
10.79%
RETURN ON EQUITY (ROE) AVG TTM
9.71%
RETURN ON EQUITY (ROE) AVG 3Y
9.35%
RETURN ON EQUITY (ROE) AVG 5Y
12.84%
RETURN ON EQUITY (ROE) AVG 10Y
12.85%
RETURN ON EQUITY (ROE) AVG 15Y
15.46%
RETURN ON EQUITY (ROE) AVG 20Y
17.65%
CURRENT VS TTM AVG
+11.07%
CURRENT VS 3Y AVG
+15.37%
CURRENT VS 5Y AVG
-15.97%
CURRENT VS 10Y AVG
-16.05%
CURRENT VS 15Y AVG
-30.22%
CURRENT VS 20Y AVG
-38.87%
LH Competitors' Return on Equity (ROE)
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Labcorp Holdings Inc. (LH) | $21.83B | 10.79% | 9.71% | 9.35% | 12.84% |
| Mettler-Toledo International Inc. (MTD) | $22.86B | -3677.41% | -2178.82% | -341.14% | -117.12% |
| BioNTech SE (BNTX) | $22.90B | -6.79% | -4.55% | 10.63% | 21.70% |
| United Therapeutics Corporation (UTHR) | $23.17B | 21.82% | 18.68% | 17.25% | 16.03% |
| Waters Corporation (WAT) | $23.17B | 2.94% | 29.98% | 64.02% | 111.55% |
| Moderna, Inc. (MRNA) | $19.80B | -43.12% | -32.64% | -13.90% | 0.25% |
| Veeva Systems Inc. (VEEV) | $25.92B | 12.89% | 12.42% | 12.32% | 13.45% |
| Hologic, Inc. (HOLX) | $16.97B | 10.37% | 13.30% | 15.60% | 24.66% |
| DexCom, Inc. (DXCM) | $29.08B | 31.47% | 28.93% | 25.01% | 22.95% |
| Biogen Inc. (BIIB) | $29.53B | 7.36% | 8.42% | 11.86% | 16.52% |
Return Analysis
ROE
10.8%
ROA
4.9%
Labcorp Holdings Inc. Return on Equity (ROE) Formula & Definition
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Labcorp Holdings Inc. Return on Equity (ROE) FAQ
- What is the return on equity (ROE) for Labcorp Holdings Inc. (LH)?
- The return on equity (ROE) for LH stock is 10.79%.
- Is Labcorp Holdings Inc.'s return on equity (ROE) high or low?
- Labcorp Holdings Inc.'s return on equity (ROE) of 10.79% is 16% below its 5-year average of 12.84%, around the middle of its 5-year range (5.31%–23.14%).
- What is the TTM average return on equity (ROE) for Labcorp Holdings Inc. (LH)?
- The TTM average return on equity (ROE) for LH stock is 9.71%.
- What is the 3Y average return on equity (ROE) for Labcorp Holdings Inc. (LH)?
- The 3Y average return on equity (ROE) for LH stock is 9.35%.
- What is the 5Y average return on equity (ROE) for Labcorp Holdings Inc. (LH)?
- The 5Y average return on equity (ROE) for LH stock is 12.84%.
- What is the 10Y average return on equity (ROE) for Labcorp Holdings Inc. (LH)?
- The 10Y average return on equity (ROE) for LH stock is 12.85%.
- What is the 15Y average return on equity (ROE) for Labcorp Holdings Inc. (LH)?
- The 15Y average return on equity (ROE) for LH stock is 15.46%.
- What is the 20Y average return on equity (ROE) for Labcorp Holdings Inc. (LH)?
- The 20Y average return on equity (ROE) for LH stock is 17.65%.
Labcorp Holdings Inc. Return on Equity (ROE) History
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | 10.17% |
| 2024-12-31 | 9.26% |
| 2023-12-31 | 5.31% |
| 2022-12-31 | 12.67% |
| 2021-12-31 | 23.14% |
| 2020-12-31 | 16.49% |
| 2019-12-31 | 10.89% |
| 2018-12-31 | 12.68% |
| 2017-12-31 | 18.64% |
| 2016-12-31 | 13.30% |
| 2015-12-31 | 8.84% |
| 2014-12-31 | 18.12% |
| 2013-12-31 | 23.03% |
| 2012-12-31 | 21.46% |
| 2011-12-31 | 20.76% |
| 2010-12-31 | 22.63% |
| 2009-12-31 | 25.80% |
| 2008-12-31 | 27.51% |
| 2007-12-31 | 27.64% |
| 2006-12-31 | 21.83% |
| 2005-12-31 | 20.48% |
| 2004-12-31 | 18.16% |
| 2003-12-31 | 16.93% |
| 2002-12-31 | 15.80% |
| 2001-12-31 | 16.54% |
| 2000-12-31 | 12.78% |
| 1999-12-31 | 8.91% |
| 1998-12-31 | 10.10% |
| 1997-12-31 | -16.97% |
| 1996-12-31 | -59.47% |
Related Metrics
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter